메뉴 건너뛰기
Annals of Oncology
Volumn 12, Issue 5, 2001, Pages 585-586
The role of cisplatin in the treatment of small-cell lung cancer?
Author keywords

[No Author keywords available]
Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; TENIPOSIDE; VINCRISTINE; VINDESINE;
EID: 0034994626     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011157008014     Document Type: Editorial
Times cited : (3)
References (13)
  • 1
    • 0025309997 scopus 로고
    • A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer
    • EORTC Lung cancer Working Party.
    • (1990) Ann Oncol , vol.1 , pp. 128-133
    • Sculier, J.P.1    Klastersky, J.2    Libert, P.3
  • 2
    • 0033432770 scopus 로고    scopus 로고
    • The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma: A randomized study of 457 patients
    • 'Petites Cellules' Group
    • (1999) Cancer , vol.86 , pp. 2238-2245
    • Urban, T.1    Chastang, C.2    Lebas, F.X.3
  • 3
    • 0033797356 scopus 로고    scopus 로고
    • A systematic review of the role of etoposide and cisplatin in the chemotherapy of small-cell lung cancer with methodology assessment and meta-analysis
    • (2000) Lung Cancer , vol.30 , pp. 23-36
    • Mascaux, C.1    Paesmans, M.2    Berghmans, T.3
  • 4
    • 0034129381 scopus 로고    scopus 로고
    • Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen vs. a regimen without this alkylating agent
    • (2000) Br J Cancer , vol.83 , pp. 8-15
    • Pujol, J.1    Carestia2    Daurès, J.P.3
  • 6
    • 0028149937 scopus 로고
    • Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
    • (1994) J Clin Oncol , vol.12 , pp. 2022-2034
    • Ihde, D.C.1    Mulshine, J.L.2    Kramer, B.S.3
  • 7
    • 0030900127 scopus 로고    scopus 로고
    • Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: A multicenter randomized phase III study
    • (1997) J Clin Oncol , vol.15 , pp. 2082-2089
    • Pujol, J.1    Douillard, J.Y.2    Rivière, A.3
  • 8
    • 0030037201 scopus 로고    scopus 로고
    • Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer
    • A randomized trial with five years follow-up.
    • (1996) Ann Oncol , vol.7 , pp. 365-371
    • Lassen, U.1    Kristjansen, P.E.G.2    Osterlind, K.3
  • 10
    • 0034988286 scopus 로고    scopus 로고
    • Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: A prospective randomised trial of 280 consecutive patients
    • (this issue)
    • (2001) Ann Oncol , vol.12 , pp. 647-653
    • Hirsch, F.R.1    Østerlind, K.2    Jeppesen, N.3
  • 11
    • 0028158537 scopus 로고
    • Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer
    • (1994) J Clin Oncol , vol.12 , pp. 353-359
    • Sculier, J.P.1    Klastersky, J.2    Giner, V.3
  • 13
    • 0033764530 scopus 로고    scopus 로고
    • Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer
    • (2000) Br J Cancer , vol.83 , pp. 1128-1135
    • Sculier, J.P.1    Lafitte, J.J.2    Paesmans, M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.